The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay

[1]  C. de Beer,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Activity by Purified Human Breast Milk Mucin (MUC1) in an Inhibition Assay , 2007, Neonatology.

[2]  G. Kotwal,et al.  Antiviral Activity of Purified Human Breast Milk Mucin , 2007, Neonatology.

[3]  P. Goldberg,et al.  Biochemical and immunohistochemical characterisation of mucins in 8 cases of colonic disease--a pilot study. , 2007, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

[4]  C. de Beer,et al.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay , 2006, Virology Journal.

[5]  M. Weinstein,et al.  Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  C. Lombard,et al.  Masking through averages--intraprovincial heterogeneity in HIV prevalence within the Western Cape. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[7]  U. Govender.  The biochemical and molecular characterisation of respiratory mucins in TB , 2006 .

[8]  C. Slack,et al.  HIV vaccine research--South Africa's ethical-legal framework and its ability to promote the welfare of trial participants. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[9]  S. Kalichman,et al.  HIV prevalence in three predominantly Muslim residential areas in the Cape Town metropole. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[10]  I. Gipson,et al.  Variation in the amount of T antigen and N-acetyllactosamine oligosaccharides in human cervical mucus secretions with the menstrual cycle. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  S. Engelbrecht,et al.  Genotypic and phenotypic analysis of the env gene from South African HIV‐1 subtype B and C isolates , 2002, Journal of medical virology.

[12]  M. Millar,et al.  Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract , 2001, Sexually transmitted infections.

[13]  I. Gipson,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle* , 2022 .

[14]  K. Carraway,et al.  Sialomucin complex (Muc4) expression in the rat female reproductive tract. , 1999, Biology of reproduction.

[15]  J. Hoxie,et al.  Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. , 1999, AIDS research and human retroviruses.

[16]  S. Freel,et al.  Endogenous salivary inhibitors of human immunodeficiency virus. , 1999, Archives of oral biology.

[17]  N. Packer,et al.  Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. , 1999, Glycobiology.

[18]  N. Packer,et al.  Salivary mucin MG 1 is comprised almost entirely of different glycosylated forms of the MUC 5 B gene product , 1999 .

[19]  E. Veerman,et al.  MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. , 1998, The Biochemical journal.

[20]  N. Uldbjerg,et al.  Cervical mucins affect the motility of human spermatozoa in vitro. , 1998, Fertility and sterility.

[21]  S. Wahl,et al.  The role of the oral environment in HIV-1 transmission. , 1998, Journal of the American Dental Association.

[22]  H. Friedman,et al.  Inhibition of HIV infectivity by human saliva. , 1997, Oral diseases.

[23]  I. Gipson,et al.  Mucin genes expressed by human female reproductive tract epithelia. , 1997, Biology of reproduction.

[24]  H. Friedman,et al.  Human submandibular saliva specifically inhibits HIV type 1. , 1997, AIDS research and human retroviruses.

[25]  C. Kublin,et al.  Stratified squamous epithelia produce mucin-like glycoproteins. , 1995, Tissue & cell.

[26]  A. Schaeffer,et al.  Binding of type 1-piliated Escherichia coli to vaginal mucus , 1995, Infection and immunity.

[27]  L. Epstein,et al.  Interaction of HIV-1 and human salivary mucins. , 1994, Journal of acquired immune deficiency syndromes.

[28]  H. Friedman,et al.  Human submandibular saliva aggregates HIV. , 1993, AIDS research and human retroviruses.

[29]  G. Cole,et al.  In vitro inhibition of HIV-1 infectivity by human salivas. , 1990, AIDS research and human retroviruses.

[30]  M. Gonda,et al.  Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. , 1987, AIDS research and human retroviruses.

[31]  U. Ulmsten,et al.  Isolation and characterization of human cervical-mucus glycoproteins. , 1983, The Biochemical journal.

[32]  U. Ulmsten,et al.  Isolation and purification of the mucin component of human cervical mucus. , 1982, Advances in experimental medicine and biology.

[33]  A. Allen,et al.  A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain [proceedings]. , 1978, Biochemical Society transactions.

[34]  J. M. Creeth,et al.  Constituents of mucus and their separation. , 1978, British medical bulletin.

[35]  R. D. Francis,et al.  Some biological and physical properties of molluscum contagiosum virus propagated in cell culture , 1976, Journal of virology.

[36]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[37]  J. M. Creeth,et al.  The use of equilibrium-density-gradient methods for the preparation and characterization of blood-group-specific glycoproteins. , 1970, The Biochemical journal.

[38]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.